Materiały źródłowe

• #1 Inflammatory bowel disease (IBD) – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/inflammatory-bowel-disease/diagnosis-treatment/drc-20353320

  The goal of inflammatory bowel disease treatment is to reduce the inflammation that triggers symptoms. In the best cases, this may lead not only to symptom relief but also to long-term remission and reduced risk of complications. IBD treatment usually involves either medicines or surgery. […] Anti-inflammatory medicines are often the first step in the treatment of ulcerative colitis, typically for mild to moderate disease. Anti-inflammatories include aminosalicylates, such as mesalamine (Delzicol, Rowasa, others), balsalazide (Colazal) and olsalazine (Dipentum). […] Time-limited courses of corticosteroids also are used to induce remission. In addition to being anti-inflammatory, steroids are immunosuppressing. The type of medicine recommended depends on the area of the colon that’s affected.

• #2 Treatment of Inflammatory Bowel Disease: A Comprehensive Review

  https://pmc.ncbi.nlm.nih.gov/articles/PMC8720971/

  Recent progress in therapeutic approaches, especially the emergence of biologics, has not only promoted the transformation of the treatment mode in IBD, but also changed the perspective of IBD therapy. Traditionally, the therapeutic effects are mainly evaluated through clinical symptom score. Nowadays, the disease activity can also be assessed by objective indicators such as endoscopic findings and biomarkers. The goals are not only to induce and maintain remission in symptom, to prevent and treat complications but also to achieve mucosal healing. Mucosal healing refers to the elimination of local mucosal inflammation and the restoration of the normal mucosal structure. Although there is still no unified criteria for the determination of mucosal healing, it is usually characterized by the disappearance of endoscopic ulcer. Multiple studies are emerging to show that mucosal healing may be associated with reduced rates of clinical recurrence, hospitalization, surgery and disability, and a good long-term prognosis.

• #3 Treatment and Medication

  https://crohnsandcolitis.ca/About-Crohn-s-Colitis/IBD-Journey/Treatment-and-Medications/Goals-of-Therapy

  The goal in the treatment of IBD inflammation is to make you feel better (induce remission), minimize side effects from medications, and also to induce mucosal healing. This is the actual healing of the mucosa, or lining, of your gut. We want to not only improve your IBD symptoms but also to improve the health of your gut itself, and then maintain that improvement. A healthier gut leads to feeling better in the long term. […] The traditional approach to treatment of IBD inflammation is referred to as step up therapy, which means trying lower classes of medications first and progressing to stronger medications if needed. Medications called 5-ASAs are the most common treatment if you have mild or moderate IBD. For severe disease, corticosteroids may be used at first. Surgery may be required, and immunosuppressants and/or biologics may also be considered.

• #4 Treatment and Medication

  https://crohnsandcolitis.ca/About-Crohn-s-Colitis/IBD-Journey/Treatment-and-Medications/Goals-of-Therapy

  Recent studies are showing that the best way to induce mucosal healing and improve symptoms is with early aggressive therapy followed by a good long-term maintenance plan. The new approach, called top-down therapy, starts with more aggressive therapy with biologics, potentially in combination with immunosuppressants, and then later using other drugs such as 5-ASAs. By using a more aggressive treatment earlier on, you may achieve more complete remission and change the natural course of the disease, which can prevent flare ups down the road. […] Since IBD never goes away, once remission is achieved, you need maintenance therapy to keep the disease under control. […] When taking medications, it is very important that you stick to your treatment regimen. This means paying attention to the instructions on the drug label (i.e., take with meals), following the frequency and dosage of your medications, and renewing your medications on time.

• #5 Treatment and Medication

  https://crohnsandcolitis.ca/About-Crohn-s-Colitis/IBD-Journey/Treatment-and-Medications/Goals-of-Therapy

  Recent studies are showing that the best way to induce mucosal healing and improve symptoms is with early aggressive therapy followed by a good long-term maintenance plan. The new approach, called top-down therapy, starts with more aggressive therapy with biologics, potentially in combination with immunosuppressants, and then later using other drugs such as 5-ASAs. By using a more aggressive treatment earlier on, you may achieve more complete remission and change the natural course of the disease, which can prevent flare ups down the road. […] Since IBD never goes away, once remission is achieved, you need maintenance therapy to keep the disease under control. […] When taking medications, it is very important that you stick to your treatment regimen. This means paying attention to the instructions on the drug label (i.e., take with meals), following the frequency and dosage of your medications, and renewing your medications on time.

• #6 Treatment and Medication

  https://crohnsandcolitis.ca/About-Crohn-s-Colitis/IBD-Journey/Treatment-and-Medications/Goals-of-Therapy

  Recent studies are showing that the best way to induce mucosal healing and improve symptoms is with early aggressive therapy followed by a good long-term maintenance plan. The new approach, called top-down therapy, starts with more aggressive therapy with biologics, potentially in combination with immunosuppressants, and then later using other drugs such as 5-ASAs. By using a more aggressive treatment earlier on, you may achieve more complete remission and change the natural course of the disease, which can prevent flare ups down the road. […] Since IBD never goes away, once remission is achieved, you need maintenance therapy to keep the disease under control. […] When taking medications, it is very important that you stick to your treatment regimen. This means paying attention to the instructions on the drug label (i.e., take with meals), following the frequency and dosage of your medications, and renewing your medications on time.

• #7 Inflammatory bowel disease (IBD) – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/inflammatory-bowel-disease/diagnosis-treatment/drc-20353320

  The goal of inflammatory bowel disease treatment is to reduce the inflammation that triggers symptoms. In the best cases, this may lead not only to symptom relief but also to long-term remission and reduced risk of complications. IBD treatment usually involves either medicines or surgery. […] Anti-inflammatory medicines are often the first step in the treatment of ulcerative colitis, typically for mild to moderate disease. Anti-inflammatories include aminosalicylates, such as mesalamine (Delzicol, Rowasa, others), balsalazide (Colazal) and olsalazine (Dipentum). […] Time-limited courses of corticosteroids also are used to induce remission. In addition to being anti-inflammatory, steroids are immunosuppressing. The type of medicine recommended depends on the area of the colon that’s affected.

• #8 Medications for Inflammatory Bowel Disease – Gastrointestinal Disorders – Merck Manual Professional Edition

  https://www.merckmanuals.com/professional/gastrointestinal-disorders/inflammatory-bowel-disease-ibd/medications-for-inflammatory-bowel-disease

  Several classes of medications are helpful for inflammatory bowel disease (IBD). […] 5-ASA blocks production of prostaglandins and leukotrienes and has other beneficial effects on the inflammatory cascade. […] Corticosteroids, beginning at high doses, are useful for acute flare-ups of most forms of IBD when 5-ASA compounds are inadequate. […] The antimetabolites azathioprine, 6-mercaptopurine, and methotrexate are also used in combination therapy with biologic agents. […] Infliximab, certolizumab, adalimumab, and golimumab are antibodies to tumor necrosis factor (TNF). […] Monotherapy with anti-TNF agents is clearly effective for both induction and maintenance of remission, but some studies suggest better results when anti-TNF agents are initiated in combination with a thiopurine (eg, azathioprine) or methotrexate.

• #9 Inflammatory bowel disease (IBD) – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/inflammatory-bowel-disease/diagnosis-treatment/drc-20353320

  The goal of inflammatory bowel disease treatment is to reduce the inflammation that triggers symptoms. In the best cases, this may lead not only to symptom relief but also to long-term remission and reduced risk of complications. IBD treatment usually involves either medicines or surgery. […] Anti-inflammatory medicines are often the first step in the treatment of ulcerative colitis, typically for mild to moderate disease. Anti-inflammatories include aminosalicylates, such as mesalamine (Delzicol, Rowasa, others), balsalazide (Colazal) and olsalazine (Dipentum). […] Time-limited courses of corticosteroids also are used to induce remission. In addition to being anti-inflammatory, steroids are immunosuppressing. The type of medicine recommended depends on the area of the colon that’s affected.

• #10 Treatment of Inflammatory Bowel Disease: A Comprehensive Review

  https://pmc.ncbi.nlm.nih.gov/articles/PMC8720971/

  In this review, we not only focus on drugs and therapies that have been approved, but also focus on the potential methods for the treatment of IBD, providing a comprehensive overview for clinicians of available therapies and drugs for IBD treatment. […] At present, pharmacological intervention is important for IBD treatment. The medications mainly include aminosalicylates, CSs, immunomodulators, biologics, and oral small molecules. […] The therapeutic efficacy of aminosalicylic acid preparations for CD remains controversial. A review has suggested that oral 5-ASA preparations have no significant advantage in maintaining remission in patients with CD. However, a retrospective study in the UK found that 5-ASA was widely used as a long-term treatment for CD as about a quarter of patients continued to use 5-ASA for more than 10 years. 5-ASA therapy for more than a year could reduce the consumption of related medical resources (including referrals, hospitalization, and surgery).

• #11 Treatment of Inflammatory Bowel Disease: A Comprehensive Review

  https://pmc.ncbi.nlm.nih.gov/articles/PMC8720971/

  Oral CSs have been used for IBD treatment since the 1950s, and can effectively induce remission when a flare occurs. CSs combine with CSs receptors in the cytoplasm, and then CSs receptors are activated. The activated CSs receptors could get into the nucleus and interact with specific proinflammatory transcription factors, which will recruit co-activator complexes to inhibit the transcription of some inflammatory genes. Moreover, activated CSs receptors can also bind to specific response elements in the promoter region of anti-inflammatory genes in the nucleus to regulate the expression of anti-inflammatory genes. […] Studies related to CSs’ efficacy in IBD are presented in Table 2. Systematic reviews and metanalyses have proved the benefits of CSs in inducing remission of IBD. A recent study demonstrated that CSs were more effective than 5-ASA in the treatment of CD. Other studies have also reported the efficacy and safety of CSs in IBD treatment.

• #12 Treatment of Inflammatory Bowel Disease: A Comprehensive Review

  https://pmc.ncbi.nlm.nih.gov/articles/PMC8720971/

  Oral CSs have been used for IBD treatment since the 1950s, and can effectively induce remission when a flare occurs. CSs combine with CSs receptors in the cytoplasm, and then CSs receptors are activated. The activated CSs receptors could get into the nucleus and interact with specific proinflammatory transcription factors, which will recruit co-activator complexes to inhibit the transcription of some inflammatory genes. Moreover, activated CSs receptors can also bind to specific response elements in the promoter region of anti-inflammatory genes in the nucleus to regulate the expression of anti-inflammatory genes. […] Studies related to CSs’ efficacy in IBD are presented in Table 2. Systematic reviews and metanalyses have proved the benefits of CSs in inducing remission of IBD. A recent study demonstrated that CSs were more effective than 5-ASA in the treatment of CD. Other studies have also reported the efficacy and safety of CSs in IBD treatment.

• #13 Treatment of Inflammatory Bowel Disease: A Comprehensive Review

  https://pmc.ncbi.nlm.nih.gov/articles/PMC8720971/

  Oral CSs have been used for IBD treatment since the 1950s, and can effectively induce remission when a flare occurs. CSs combine with CSs receptors in the cytoplasm, and then CSs receptors are activated. The activated CSs receptors could get into the nucleus and interact with specific proinflammatory transcription factors, which will recruit co-activator complexes to inhibit the transcription of some inflammatory genes. Moreover, activated CSs receptors can also bind to specific response elements in the promoter region of anti-inflammatory genes in the nucleus to regulate the expression of anti-inflammatory genes. […] Studies related to CSs’ efficacy in IBD are presented in Table 2. Systematic reviews and metanalyses have proved the benefits of CSs in inducing remission of IBD. A recent study demonstrated that CSs were more effective than 5-ASA in the treatment of CD. Other studies have also reported the efficacy and safety of CSs in IBD treatment.

• #14 Frequently Asked Questions About Inflammatory Bowel Disease (IBD) | University of Michigan Health

  https://www.uofmhealth.org/conditions-treatments/digestive-and-liver-health/crohns-faq

  However, for many, all these risks are outweighed by the risks of complications of IBD, which accumulate over time. […] Narcotics treat the symptoms, not the cause (inflammation) of IBD. Narcotics can make the inflammation worse. Research has shown that patients with IBD who use narcotics are more likely to have severe abdominal infections (abscesses), strictures and intestinal obstruction. We try to avoid prescribing narcotics for IBD because they seem to be harmful. […] Prednisone has many side effects, including bone loss, diabetes, cataracts, emotional distress and severe acne, which make us want to minimize the use of prednisone as much as possible. In addition, the longer prednisone or other steroids are used, the less likely they are to work. That’s why we like to save prednisone for when (and if) you really need it to rescue you from a flare. Maintenance medicines are designed to reduce your flares in both number and severity. Therefore, you shouldn’t need to take prednisone as often. There is also evidence that taking maintenance medicine and reducing inflammation in the colon reduces colon cancer.

• #15 Inflammatory Bowel Disease Treatment & Management: Approach Considerations, Symptomatic Therapy/Supportive Care, Overview of Therapy

  https://emedicine.medscape.com/article/179037-treatment

  For a flare of moderate severity, a dose of prednisone of 20-40 mg/day or equivalent is often sufficient to treat the flares. Once symptoms are controlled, a dedicated tapering of the steroid dose follows. […] Patients are candidates for immunomodulators (azathioprine, 6-mercaptopurine, methotrexate) or anti-TNF agents (infliximab, adalimumab, certolizumab pegol) and biologic agents if flares are frequent (1-2 times), if the duration of steroid use is prolonged (more than a few weeks per year), if reduction of the steroid dose causes recurrence of symptoms (steroid dependent), or if steroids do not appear to be working (steroid refractory). […] The first step in medication therapy for mild IBD is usually aminosalicylates. There are several different aminosalicylates, but none have been consistently demonstrated to be superior to the others for all patients.

• #16 Treatment of Inflammatory Bowel Disease: A Comprehensive Review

  https://pmc.ncbi.nlm.nih.gov/articles/PMC8720971/

  Immunomodulators are important for patients with IBD and mainly include thiopurines, methotrexate, calcineurin inhibitors, and Janus Kinase inhibitors. […] Biologics mainly include pro-inflammatory cytokine inhibitors and integrin antagonists. The pro-inflammatory cytokines, TNF- and IL-12/23, play an important role in the pathogenesis of IBD. […] Multiple studies have suggested that IL-12/23 and IL-23 antagonists are potential therapeutic options for IBD treatment. Experts recommended IL-12/23 and IL-23 antagonists as a first- or second-line therapy because of their efficacy in biologic-nave and experienced patients. […] With the development of biologics, significant progress has been made in the drug treatment of IBD, but surgery is still an important means for IBD treatment. […] Apheresis therapy is a novel treatment for IBD developed in Japan, whose main mechanism is to reduce the local inflammatory response by isolating and absorbing one or more specific leukocytes in the peripheral blood.

• #17 Medication for Inflammatory Bowel Disease | NYU Langone Health

  https://nyulangone.org/conditions/inflammatory-bowel-disease/treatments/medication-for-inflammatory-bowel-disease

  Corticosteroid medications are powerful anti-inflammatory agents and are often used short-term to relieve symptoms quickly. […] Doctors may prescribe 5-aminosalicylic acid medications, known as 5-ASAs, for people with mild to moderate IBD. […] Immunomodulator medications suppress or regulate certain aspects of the immune system, counteracting the bodys abnormal response to food and bacteria in the digestive tract. […] Biologic therapies, sometimes called biologics, are a class of medications that reduce intestinal inflammation by targeting specific immune system responses. […] Gastroenterologists may prescribe anti-TNF medicationswhich block proteins that cause inflammation in the digestive tractif IBD is moderate to severe at the time of diagnosis or if your symptoms have not responded to other medical treatments.

• #18 Inflammatory Bowel Disease Treatment & Management: Approach Considerations, Symptomatic Therapy/Supportive Care, Overview of Therapy

  https://emedicine.medscape.com/article/179037-treatment

  For a flare of moderate severity, a dose of prednisone of 20-40 mg/day or equivalent is often sufficient to treat the flares. Once symptoms are controlled, a dedicated tapering of the steroid dose follows. […] Patients are candidates for immunomodulators (azathioprine, 6-mercaptopurine, methotrexate) or anti-TNF agents (infliximab, adalimumab, certolizumab pegol) and biologic agents if flares are frequent (1-2 times), if the duration of steroid use is prolonged (more than a few weeks per year), if reduction of the steroid dose causes recurrence of symptoms (steroid dependent), or if steroids do not appear to be working (steroid refractory). […] The first step in medication therapy for mild IBD is usually aminosalicylates. There are several different aminosalicylates, but none have been consistently demonstrated to be superior to the others for all patients.

• #19 Inflammatory Bowel Disease Treatment & Management: Approach Considerations, Symptomatic Therapy/Supportive Care, Overview of Therapy

  https://emedicine.medscape.com/article/179037-treatment

  If the patient’s condition fails to respond to an adequate dose of aminosalicylates, the second step is often corticosteroids, which tend to provide rapid relief of symptoms and a significant decrease in inflammation. […] The immune-modifying agents are used if corticosteroids fail or are required for prolonged periods for milder disease; they can be used up front for moderate and severe disease. Anti-TNF monoclonal antibody therapies are also effective in both Crohn disease and ulcerative colitis; some studies have demonstrated that they have a greater efficacy than azathioprine. […] In general, one major goal is to wean the patient off steroids as soon as possible to prevent long-term adverse effects from these agents. […] Immune modifiers have a slower onset of action (typically, a 2- to 3-month lag) and, consequently, are not used for induction of remission. However, these agents have shown effectiveness for their steroid-sparing action in persons with refractory disease; they are also used as primary treatment for fistulas and maintenance of remission in patients intolerant of or not responsive to aminosalicylates.

• #20 Inflammatory bowel disease (IBD) – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/inflammatory-bowel-disease/diagnosis-treatment/drc-20353320

  These drugs work in a variety of ways to suppress the immune response that releases inflammation-inducing chemicals into the body. When released, these chemicals can damage the lining of the digestive tract. […] More recently, medicines given by mouth that are known as small molecules have become available for IBD treatment. Janus kinase inhibitors, also called JAK inhibitors, are a type of small molecule medicine that helps reduce inflammation by targeting parts of the immune system that cause inflammation in the intestines. Some JAK inhibitors for IBD include tofacitinib (Xeljanz) and upadacitinib (Rinvoq). […] Biologics are a newer category of therapy in which treatment is directed toward neutralizing proteins in the body that are causing inflammation. Some of these medicines are administered via intravenous, also called IV, infusions and others are injections you give yourself. Examples include infliximab (Remicade), adalimumab (Humira), golimumab (Simponi), certolizumab (Cimzia), vedolizumab (Entyvio), ustekinumab (Stelara) and risankizumab (Skyrizi).

• #21 Biologics and Inflammatory Bowel Disease (IBD) – UChicago Medicine

  https://www.uchicagomedicine.org/conditions-services/inflammatory-bowel-disease/treatment/biologics-and-inflammatory-bowel-disease-ibd-crohns-colitis

  Biologics are used to treat IBD because they help the immune system target certain proteins that cause inflammation. […] Biologics interrupt these attacks by mimicking proteins that the body naturally makes on its own to turn down the immune system. […] Many classes of biologics are available to treat IBD, including Tumor necrosis factor-alpha (TNF-alpha) blockers, Integrin blockers, and Interleukin blockers. […] Your GI specialist will determine which biologic is right for you based on a number of factors. […] Within days or weeks of starting on a biologic, you may notice your symptoms becoming less severe. […] You and your GI specialist may decide to switch your biologic for several reasons. […] At UChicago Medicine, we will closely monitor you for side effects and make sure you are on the best biologic for you. […] Biological therapies have been real big breakthroughs for us and for our patients. […] There are many reasons why we may decide to change your therapy. […] I hope this has been a helpful review for some of the reasons why we might change biological therapies.

• #22 Biologics and Inflammatory Bowel Disease (IBD) – UChicago Medicine

  https://www.uchicagomedicine.org/conditions-services/inflammatory-bowel-disease/treatment/biologics-and-inflammatory-bowel-disease-ibd-crohns-colitis

  Biologics are used to treat IBD because they help the immune system target certain proteins that cause inflammation. […] Biologics interrupt these attacks by mimicking proteins that the body naturally makes on its own to turn down the immune system. […] Many classes of biologics are available to treat IBD, including Tumor necrosis factor-alpha (TNF-alpha) blockers, Integrin blockers, and Interleukin blockers. […] Your GI specialist will determine which biologic is right for you based on a number of factors. […] Within days or weeks of starting on a biologic, you may notice your symptoms becoming less severe. […] You and your GI specialist may decide to switch your biologic for several reasons. […] At UChicago Medicine, we will closely monitor you for side effects and make sure you are on the best biologic for you. […] Biological therapies have been real big breakthroughs for us and for our patients. […] There are many reasons why we may decide to change your therapy. […] I hope this has been a helpful review for some of the reasons why we might change biological therapies.

• #23 Overview of TNF Inhibitors for Treating Inflammatory Bowel Disease

  https://www.uspharmacist.com/article/overview-of-tnf-inhibitors-for-treating-inflammatory-bowel-disease

  There are four anti-TNF agents currently recommended by multiple guidelines and indicated for the treatment of moderately to severely active IBD. Infliximab and adalimumab are used in treating UC and CD. […] A review of American Gastroenterological Association (AGA) and American College of Gastroenterology (ACG) guidelines indicates the recommendation of infliximab, adalimumab, and certolizumab pegol for induction of remission and maintenance therapy in patients with moderately severe CD. […] The National Institute for Health and Care Excellence (NICE) guidelines recommend infliximab or adalimumab as therapy options for adults with severe active CD in patients who are not responsive to conventional therapy. […] For the induction and maintenance of remission in moderately to severely active UC, AGA and ACG guidelines mirror the indications for these agents and recommend the use of anti-TNF agents, specifically infliximab, adalimumab, and golimumab.

• #24 Inflammatory bowel disease (IBD) – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/inflammatory-bowel-disease/diagnosis-treatment/drc-20353320

  These drugs work in a variety of ways to suppress the immune response that releases inflammation-inducing chemicals into the body. When released, these chemicals can damage the lining of the digestive tract. […] More recently, medicines given by mouth that are known as small molecules have become available for IBD treatment. Janus kinase inhibitors, also called JAK inhibitors, are a type of small molecule medicine that helps reduce inflammation by targeting parts of the immune system that cause inflammation in the intestines. Some JAK inhibitors for IBD include tofacitinib (Xeljanz) and upadacitinib (Rinvoq). […] Biologics are a newer category of therapy in which treatment is directed toward neutralizing proteins in the body that are causing inflammation. Some of these medicines are administered via intravenous, also called IV, infusions and others are injections you give yourself. Examples include infliximab (Remicade), adalimumab (Humira), golimumab (Simponi), certolizumab (Cimzia), vedolizumab (Entyvio), ustekinumab (Stelara) and risankizumab (Skyrizi).

• #25 Biologics and Inflammatory Bowel Disease (IBD) – UChicago Medicine

  https://www.uchicagomedicine.org/conditions-services/inflammatory-bowel-disease/treatment/biologics-and-inflammatory-bowel-disease-ibd-crohns-colitis

  Vedolizumab is a very exciting addition to the group of medicines that we use to treat patients with inflammatory bowel disease. […] This medication is given by an IV every two months, although the first few months you get three doses kind of as a kick off to get your body set with the drug. […] One of the nice things about vedolizumab, it’s that we have some patients who can’t be on other medicines because of problems they may have elsewhere in the body, such as previous lung infections or skin problems and joint issues. […] Biologic medicines, also known as biologics, have been shown to be very safe and effective in people with inflammatory bowel disease (IBD). […] Starting on these medications early in the course of your treatment can help you achieve remission and relief from your symptoms more quickly.

• #26 Biologics and Inflammatory Bowel Disease (IBD) – UChicago Medicine

  https://www.uchicagomedicine.org/conditions-services/inflammatory-bowel-disease/treatment/biologics-and-inflammatory-bowel-disease-ibd-crohns-colitis

  Vedolizumab is a very exciting addition to the group of medicines that we use to treat patients with inflammatory bowel disease. […] This medication is given by an IV every two months, although the first few months you get three doses kind of as a kick off to get your body set with the drug. […] One of the nice things about vedolizumab, it’s that we have some patients who can’t be on other medicines because of problems they may have elsewhere in the body, such as previous lung infections or skin problems and joint issues. […] Biologic medicines, also known as biologics, have been shown to be very safe and effective in people with inflammatory bowel disease (IBD). […] Starting on these medications early in the course of your treatment can help you achieve remission and relief from your symptoms more quickly.

• #27 Inflammatory bowel disease (IBD) – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/inflammatory-bowel-disease/diagnosis-treatment/drc-20353320

  These drugs work in a variety of ways to suppress the immune response that releases inflammation-inducing chemicals into the body. When released, these chemicals can damage the lining of the digestive tract. […] More recently, medicines given by mouth that are known as small molecules have become available for IBD treatment. Janus kinase inhibitors, also called JAK inhibitors, are a type of small molecule medicine that helps reduce inflammation by targeting parts of the immune system that cause inflammation in the intestines. Some JAK inhibitors for IBD include tofacitinib (Xeljanz) and upadacitinib (Rinvoq). […] Biologics are a newer category of therapy in which treatment is directed toward neutralizing proteins in the body that are causing inflammation. Some of these medicines are administered via intravenous, also called IV, infusions and others are injections you give yourself. Examples include infliximab (Remicade), adalimumab (Humira), golimumab (Simponi), certolizumab (Cimzia), vedolizumab (Entyvio), ustekinumab (Stelara) and risankizumab (Skyrizi).

• #28 Inflammatory bowel disease (IBD) – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/inflammatory-bowel-disease/diagnosis-treatment/drc-20353320

  These drugs work in a variety of ways to suppress the immune response that releases inflammation-inducing chemicals into the body. When released, these chemicals can damage the lining of the digestive tract. […] More recently, medicines given by mouth that are known as small molecules have become available for IBD treatment. Janus kinase inhibitors, also called JAK inhibitors, are a type of small molecule medicine that helps reduce inflammation by targeting parts of the immune system that cause inflammation in the intestines. Some JAK inhibitors for IBD include tofacitinib (Xeljanz) and upadacitinib (Rinvoq). […] Biologics are a newer category of therapy in which treatment is directed toward neutralizing proteins in the body that are causing inflammation. Some of these medicines are administered via intravenous, also called IV, infusions and others are injections you give yourself. Examples include infliximab (Remicade), adalimumab (Humira), golimumab (Simponi), certolizumab (Cimzia), vedolizumab (Entyvio), ustekinumab (Stelara) and risankizumab (Skyrizi).

• #29 Inflammatory Bowel Disease Treatment & Management: Approach Considerations, Symptomatic Therapy/Supportive Care, Overview of Therapy

  https://emedicine.medscape.com/article/179037-treatment

  The oral JAK inhibitor tofacitinib (Xeljanz) has been approved for the treatment of moderate to severe ulcerative colitis. […] Infliximab (Remicade) is an anti-TNF-alpha monoclonal antibody that is administered by infusion for the treatment of Crohn disease. Infliximab is FDA approved for both ulcerative colitis and Crohn disease; it appears to have a higher efficacy rate in Crohn disease. […] Cessation of infliximab therapy, even in patients who are in prolonged remission, is associated with high rates of disease flare. […] Adverse effects of infliximab are uncommon but can include hypersensitivity and flulike symptoms; the latter can often be avoided by pretreatment with acetaminophen and diphenhydramine.

• #30 Horizon scanning: new and future therapies in the management of inflammatory bowel disease | eGastroenterology

  https://egastroenterology.bmj.com/content/1/2/e100012

  The therapeutic arsenal for the management of IBD is being developed and repurposed at an accelerated rate. […] Small molecules have the added advantage of not carrying the risk of immunogenicity that occurs with biological drugs. […] Therefore, there is potential to use these medications on demand such as during disease flares, to avoid corticosteroid use, or in combination with a biologic to improve clinical remission by targeting multiple immune pathways.

• #31 Horizon scanning: new and future therapies in the management of inflammatory bowel disease | eGastroenterology

  https://egastroenterology.bmj.com/content/1/2/e100012

  The therapeutic arsenal for the management of IBD is being developed and repurposed at an accelerated rate. […] Small molecules have the added advantage of not carrying the risk of immunogenicity that occurs with biological drugs. […] Therefore, there is potential to use these medications on demand such as during disease flares, to avoid corticosteroid use, or in combination with a biologic to improve clinical remission by targeting multiple immune pathways.

• #32 Crohn’s disease – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/crohns-disease/diagnosis-treatment/drc-20353309

  This class of therapies targets proteins made by the immune system. Types of biologics used to treat Crohn’s disease include: […] JAK inhibitors are a type of medicine known as small molecules. These newer medicines help reduce inflammation by targeting parts of the immune system that cause inflammation in the intestines. […] Antibiotics can reduce the amount of drainage from fistulas and abscesses and sometimes heal them in people with Crohn’s disease. […] If diet and lifestyle changes, medicines, or other treatments don’t relieve symptoms, a healthcare professional may recommend surgery. Nearly half of those with Crohn’s disease might require at least one surgery. However, surgery does not cure Crohn’s disease. […] The benefits of surgery for Crohn’s disease are usually temporary. The disease often recurs, often near the reconnected tissue. The best approach is to follow surgery with medicine to reduce the risk of recurrence.

• #33 Inflammatory bowel disease

  https://womenshealth.gov/a-z-topics/inflammatory-bowel-disease

  Your doctor may give you: Medicines to control inflammation, such as: Aminosalicylates, which may also help prevent flare-ups. Most people with mild to moderate ulcerative colitis and some people with Crohn’s disease are treated with aminosalicylates. […] Biologic therapies, which block substances in your body that cause inflammation […] Antibiotics, which may help if you have an infection or overgrowth of bacteria. […] Medicines to calm your immune system, such as: Corticosteroids, which are strong, fast-acting drugs to treat IBD flare-ups. […] You may need to try several different medicines before you find what works best for you. […] Maybe. More than half of people with Crohn’s disease need surgery within 20 years of being diagnosed. Surgery can relieve your symptoms, but it cannot cure the disease.

• #34 Medications for Inflammatory Bowel Disease – Gastrointestinal Disorders – Merck Manual Professional Edition

  https://www.merckmanuals.com/professional/gastrointestinal-disorders/inflammatory-bowel-disease-ibd/medications-for-inflammatory-bowel-disease

  Antibiotics may be helpful in Crohn disease but are of limited use in ulcerative colitis, except in toxic colitis. […] Various nonpathogenic microorganisms (eg, commensal Escherichia coli, Lactobacillus species, Saccharomyces) given daily serve as probiotics and may be effective in preventing pouchitis, but other therapeutic roles have yet to be clearly defined.

• #35 Inflammatory bowel disease (IBD) – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/inflammatory-bowel-disease/diagnosis-treatment/drc-20353320

  If diet and lifestyle changes, drug therapy, or other treatments don’t relieve your IBD symptoms, surgery may be recommended. […] Surgery involves removal of the entire colon and rectum. An internal pouch is then made and attached to the anus. This allows the passing of stool without having a bag for stool on the outside of the body. […] Up to two-thirds of people with Crohn’s disease require at least one surgery in their lifetimes. However, surgery does not cure Crohn’s disease.

• #36 IBD Therapies: Types, Benefits, and Side Effects

  https://www.healthline.com/health/ibd-therapy

  Biologics are ideal for people with moderate to severe IBD. […] JAK inhibitors are a relatively new treatment for IBD. They block Janus kinase enzymes that help signal inflammation in the body. […] Though surgery was considered a last resort for treating IBD for decades, in recent years, some experts consider it a preferable alternative to ongoing drug therapy. […] Ultimately, though, the decision about whether to undergo surgery will occur between you and a team of healthcare professionals. In some cases, surgery may be combined with therapy. […] Anti-inflammatory therapy remains among the most common treatment options for IBD and is associated with a higher quality of life in people with the condition. However, most options come with many side effects. […] For that reason, the therapy with the least risk of adverse effects, 5-ASA drugs, is typically recommended first. […] In severe cases, therapy may also be accompanied or followed by surgical measures, like removing damaged portions of the intestine. With an individualized treatment plan, you can find relief from IBD symptoms and live well.

• #37 Inflammatory Bowel Disease (IBD) | ACG

  https://gi.org/topics/inflammatory-bowel-disease/

  Surgery in UC is performed for a number of reasons. It is generally considered to cure UC if the entire large intestine is removed. Some common reasons to need the colon removed are: No response to medications, Severe side effects of medications, No longer able to safely take medications, Develop an enlarged colon called toxic megacolon, Have many areas of dysplasia (pre-cancerous lesions), Develop cancer of the colon, Children who are not growing due to their UC.

• #38 Inflammatory bowel disease (IBD) – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/inflammatory-bowel-disease/diagnosis-treatment/drc-20353320

  If diet and lifestyle changes, drug therapy, or other treatments don’t relieve your IBD symptoms, surgery may be recommended. […] Surgery involves removal of the entire colon and rectum. An internal pouch is then made and attached to the anus. This allows the passing of stool without having a bag for stool on the outside of the body. […] Up to two-thirds of people with Crohn’s disease require at least one surgery in their lifetimes. However, surgery does not cure Crohn’s disease.

• #39

  https://www.nhs.uk/conditions/ulcerative-colitis/treatment/

  These medicines block these receptors and reduce inflammation. […] JAK inhibitors may be recommended for people with moderate to severe ulcerative colitis if standard treatments or biologics have not worked, or are not suitable. […] A medicine called ozanimod may be recommended for people with moderate to severe ulcerative colitis if standard treatments or biologic medicines have not worked or are not suitable. […] If you have frequent flare-ups that have a significant effect on your quality of life, or you have a particularly severe flare-up that’s not responding to medicines, surgery may be an option. […] Surgery for ulcerative colitis involves permanently removing the colon (a colectomy). […] As the colon is removed, ulcerative colitis cannot come back again after surgery.

• #40 Inflammatory bowel disease (IBD) – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/inflammatory-bowel-disease/diagnosis-treatment/drc-20353320

  If diet and lifestyle changes, drug therapy, or other treatments don’t relieve your IBD symptoms, surgery may be recommended. […] Surgery involves removal of the entire colon and rectum. An internal pouch is then made and attached to the anus. This allows the passing of stool without having a bag for stool on the outside of the body. […] Up to two-thirds of people with Crohn’s disease require at least one surgery in their lifetimes. However, surgery does not cure Crohn’s disease.

• #41 Inflammatory bowel disease (IBD) – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/inflammatory-bowel-disease/diagnosis-treatment/drc-20353320

  If diet and lifestyle changes, drug therapy, or other treatments don’t relieve your IBD symptoms, surgery may be recommended. […] Surgery involves removal of the entire colon and rectum. An internal pouch is then made and attached to the anus. This allows the passing of stool without having a bag for stool on the outside of the body. […] Up to two-thirds of people with Crohn’s disease require at least one surgery in their lifetimes. However, surgery does not cure Crohn’s disease.

• #42 Crohn’s disease – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/crohns-disease/diagnosis-treatment/drc-20353309

  This class of therapies targets proteins made by the immune system. Types of biologics used to treat Crohn’s disease include: […] JAK inhibitors are a type of medicine known as small molecules. These newer medicines help reduce inflammation by targeting parts of the immune system that cause inflammation in the intestines. […] Antibiotics can reduce the amount of drainage from fistulas and abscesses and sometimes heal them in people with Crohn’s disease. […] If diet and lifestyle changes, medicines, or other treatments don’t relieve symptoms, a healthcare professional may recommend surgery. Nearly half of those with Crohn’s disease might require at least one surgery. However, surgery does not cure Crohn’s disease. […] The benefits of surgery for Crohn’s disease are usually temporary. The disease often recurs, often near the reconnected tissue. The best approach is to follow surgery with medicine to reduce the risk of recurrence.

• #43 Frequently Asked Questions About Inflammatory Bowel Disease (IBD) | University of Michigan Health

  https://www.uofmhealth.org/conditions-treatments/digestive-and-liver-health/crohns-faq

  No, but surgery can be very helpful. For patients with ulcerative colitis, removal of 97% of the colon dramatically reduces symptoms. Surgery is no picnic, but it can often dramatically improve the quality of life of someone with severe colitis. […] The effect of surgery for Crohns disease can often be like pushing a giant reset button, as surgery can remove scarred tissue and strictures, fistulas and abscesses that cause a lot of symptoms for which medicines are not very effective. After surgery for Crohns disease, maintenance medicines are often more effective and help prevent further complications that lead to requiring further surgery in the future. […] There are some risks in suppressing or weakening your immune system. Viruses that stay in your body, like the chicken pox virus, are more likely to be activated (cause shingles) in people taking immunosuppressives such as azathioprine and methotrexate.

• #44 Horizon scanning: new and future therapies in the management of inflammatory bowel disease | eGastroenterology

  https://egastroenterology.bmj.com/content/1/2/e100012

  The current mainstay treatment modalities for inflammatory bowel disease (IBD) include immunomodulators (methotrexate and thiopurines), biologics (antitumour necrosis factor alpha (TNF-) being the most commonly used) and other monoclonal antibodies such as the anti-integrins and anti-interleukins (IL-12/23). […] Recently, there has been an influx of new and emerging medications entering the market that are showing promising efficacy results in patients with moderate-to-severe disease who have previously failed to respond to multiple drugs. […] This review will focus on these novel and emerging therapiesin essence, horizon scanningwhich includes the antiadhesion agents, cytokine inhibitors, Janus kinase inhibitors, phosphodiesterase inhibitors, sphingosine-1 phosphate receptor modulators and MicroRNA-124 (miR-124) upregulators.

• #45 Horizon scanning: new and future therapies in the management of inflammatory bowel disease | eGastroenterology

  https://egastroenterology.bmj.com/content/1/2/e100012

  The current mainstay treatment modalities for inflammatory bowel disease (IBD) include immunomodulators (methotrexate and thiopurines), biologics (antitumour necrosis factor alpha (TNF-) being the most commonly used) and other monoclonal antibodies such as the anti-integrins and anti-interleukins (IL-12/23). […] Recently, there has been an influx of new and emerging medications entering the market that are showing promising efficacy results in patients with moderate-to-severe disease who have previously failed to respond to multiple drugs. […] This review will focus on these novel and emerging therapiesin essence, horizon scanningwhich includes the antiadhesion agents, cytokine inhibitors, Janus kinase inhibitors, phosphodiesterase inhibitors, sphingosine-1 phosphate receptor modulators and MicroRNA-124 (miR-124) upregulators.

• #46 Treatment of Inflammatory Bowel Disease: A Comprehensive Review

  https://pmc.ncbi.nlm.nih.gov/articles/PMC8720971/

  Changes in the composition and function of the intestinal microbiota were found in patients with IBD. […] FMT is a new therapy that transplants the functional micromicrobiota from the feces of healthy donors into the gastrointestinal tract of patients suffering from intestinal microbiome disorders to reconstruct the intestinal microecology and cure disease. […] In summary, FMT is expected to be a new option for IBD treatment. Future research should focus on the donor-receptor matching based on microbial characterization, selection of administration routes, and determination of optimal intensity of treatment. Meanwhile, additional preclinical studies and clinical trials are necessary to provide data on the long-term efficacy and safety of FMT.

• #47 Treatment of Inflammatory Bowel Disease: A Comprehensive Review

  https://pmc.ncbi.nlm.nih.gov/articles/PMC8720971/

  Changes in the composition and function of the intestinal microbiota were found in patients with IBD. […] FMT is a new therapy that transplants the functional micromicrobiota from the feces of healthy donors into the gastrointestinal tract of patients suffering from intestinal microbiome disorders to reconstruct the intestinal microecology and cure disease. […] In summary, FMT is expected to be a new option for IBD treatment. Future research should focus on the donor-receptor matching based on microbial characterization, selection of administration routes, and determination of optimal intensity of treatment. Meanwhile, additional preclinical studies and clinical trials are necessary to provide data on the long-term efficacy and safety of FMT.

• #48 Treatment of Inflammatory Bowel Disease: A Comprehensive Review

  https://pmc.ncbi.nlm.nih.gov/articles/PMC8720971/

  Changes in the composition and function of the intestinal microbiota were found in patients with IBD. […] FMT is a new therapy that transplants the functional micromicrobiota from the feces of healthy donors into the gastrointestinal tract of patients suffering from intestinal microbiome disorders to reconstruct the intestinal microecology and cure disease. […] In summary, FMT is expected to be a new option for IBD treatment. Future research should focus on the donor-receptor matching based on microbial characterization, selection of administration routes, and determination of optimal intensity of treatment. Meanwhile, additional preclinical studies and clinical trials are necessary to provide data on the long-term efficacy and safety of FMT.

• #49 Current Therapy in Inflammatory Bowel Disease: Why and How We Need to Change? – European Medical Journal

  https://www.emjreviews.com/innovations/article/current-therapy-in-inflammatory-bowel-disease-why-and-how-we-need-to-change-j080121/

  Thus, it seems obvious that progress has stalled and innovative approaches to IBD therapy are needed. […] If the complexity of IBD is accepted, and the fact that the single target-single medicine approach has stalled progress, one solution is to think about IBD in a completely different way. […] This omic- and AI-based approach will drastically change the way IBD is treated as each patient will receive drugs specifically designed for their underlying mechanism of disease, unlike drugs that broadly block mechanisms of inflammation.

• #50 Current Therapy in Inflammatory Bowel Disease: Why and How We Need to Change? – European Medical Journal

  https://www.emjreviews.com/innovations/article/current-therapy-in-inflammatory-bowel-disease-why-and-how-we-need-to-change-j080121/

  Thus, it seems obvious that progress has stalled and innovative approaches to IBD therapy are needed. […] If the complexity of IBD is accepted, and the fact that the single target-single medicine approach has stalled progress, one solution is to think about IBD in a completely different way. […] This omic- and AI-based approach will drastically change the way IBD is treated as each patient will receive drugs specifically designed for their underlying mechanism of disease, unlike drugs that broadly block mechanisms of inflammation.

• #51 Current Treatments, Emerging Therapeutics, and Natural Remedies for Inflammatory Bowel Disease

  https://www.mdpi.com/1420-3049/29/16/3954

  Natural products from plants, helminths, and microbes exhibit considerable promise as anti-inflammatory agents for treating IBD, including a few already in early clinical trial phases. […] Artificial intelligence (AI)-assisted technologies, including machine learning and deep learning, have streamlined chemical structure forecasting, synthesis pathway proposals, and drug-target interaction elucidation processes. AI-assisted tools, such as molecular docking and protein-protein interaction studies, have identified promising anti-inflammatory leads such as curcumin and epigallocatechin gallate.

• #52 Current Treatments, Emerging Therapeutics, and Natural Remedies for Inflammatory Bowel Disease

  https://www.mdpi.com/1420-3049/29/16/3954

  The treatment option for IBD has further widened with the approvals of anti-integrins (vedolizumab and natalizumab), Janus kinase (JAK) inhibitors (tofacitinib, filgotinib, and upadacitinib), and anti-p19 antibodies (ustekinumab and risankizumab). […] Could combining multiple biologics be an alternative therapy to maximise efficacy with fewer side effects? Several studies have tried combination therapies (CoT) of biologics or biologics with SMD (e.g., anti-TNF + anti-integrins) against IBD. […] The advent of new biological and small-molecule therapies has made significant progress in the treatment landscape of IBD, and many more are in the pipeline. Janus kinase (JAK) inhibitors, immunosuppressants, and anti-trafficking molecules are a few examples. […] More IL-12/IL-23 inhibitors and anti-integrin/anti-adhesion agents are undergoing clinical assessment for their efficacy and safety in treating IBD.

• #53 Horizon scanning: new and future therapies in the management of inflammatory bowel disease | eGastroenterology

  https://egastroenterology.bmj.com/content/1/2/e100012

  The introduction of anti-TNF therapies in the late 1990s revolutionised the realm of medical therapy and is still considered as the best first-line treatment for both UC and CD. […] The development for subcutaneous and oral routes of administration are underway and show promising preliminary results. […] Recently, there has been an influx of new and emerging medications entering the market that are showing promising efficacy results in patients with moderate-to-severe disease who have previously failed to respond to multiple drugs. […] The subcutaneous group demonstrated clinical remission rates of 46.2% compared with 42.6% intravenous and 14.3% placebo (p0.001). […] The most common biological combination regimen is with vedolizumab and ustekinumab, vedolizumab and anti-TNF, ustekinumab and anti-TNF.

• #54 Medications for Inflammatory Bowel Disease – Gastrointestinal Disorders – Merck Manual Professional Edition

  https://www.merckmanuals.com/professional/gastrointestinal-disorders/inflammatory-bowel-disease-ibd/medications-for-inflammatory-bowel-disease

  Several classes of medications are helpful for inflammatory bowel disease (IBD). […] 5-ASA blocks production of prostaglandins and leukotrienes and has other beneficial effects on the inflammatory cascade. […] Corticosteroids, beginning at high doses, are useful for acute flare-ups of most forms of IBD when 5-ASA compounds are inadequate. […] The antimetabolites azathioprine, 6-mercaptopurine, and methotrexate are also used in combination therapy with biologic agents. […] Infliximab, certolizumab, adalimumab, and golimumab are antibodies to tumor necrosis factor (TNF). […] Monotherapy with anti-TNF agents is clearly effective for both induction and maintenance of remission, but some studies suggest better results when anti-TNF agents are initiated in combination with a thiopurine (eg, azathioprine) or methotrexate.

• #55 Inflammatory Bowel Disease Treatment & Management: Approach Considerations, Symptomatic Therapy/Supportive Care, Overview of Therapy

  https://emedicine.medscape.com/article/179037-treatment

  The concept of deep mucosal healing, particularly in Crohn disease, is becoming routine care. There are several studies, primarily involving anti-TNF agents (and occasionally immune modifiers); that have shown that the elimination of inflammation (as demonstrated by endoscopic and histologic criteria) results in a decrease in the rate of surgery, the use of corticosteroids, and the rate of hospitalization. This supports the use of immune-modifying agents (mercaptopurine or azathioprine) or one of the anti-TNF agents earlier in the course of IBD. […] In addition to treatment of the underlying inflammation, patients with inflammatory bowel disease (IBD) may require symptomatic therapy, particularly when their symptoms are not related to active inflammation. Treatment with antidiarrheal agents such as loperamide or diphenoxylate/atropine should generally be avoided in patients with active inflammation, as these drugs can precipitate toxic megacolon in individuals with significant colonic inflammation.

• #56 Medication for Inflammatory Bowel Disease | NYU Langone Health

  https://nyulangone.org/conditions/inflammatory-bowel-disease/treatments/medication-for-inflammatory-bowel-disease

  Anti-integrin therapy may be prescribed for people with severe IBD whose symptoms have not responded to other medications. […] As part of a comprehensive, personalized medical treatment plan, your gastroenterologist may prescribe or recommend medication that is not intended to address the cause of IBD. […] If a bacterial infection occurs as a complication of IBD, your doctor may prescribe antibiotics, which are taken by mouth or administered via IV infusion. […] For abdominal pain that does not respond to other IBD medications, gastroenterologists may recommend a prescription antispasmodic medication, which suppresses muscle spasms in the bowel, easing pain and discomfort. […] Gastroenterologists at NYU Langone understand that IBD symptoms can be painful. […] People with IBD often have vitamin or mineral deficiencies because digestive dysfunction prevents the body from absorbing important nutrients.

• #57 Medication for Inflammatory Bowel Disease | NYU Langone Health

  https://nyulangone.org/conditions/inflammatory-bowel-disease/treatments/medication-for-inflammatory-bowel-disease

  Anti-integrin therapy may be prescribed for people with severe IBD whose symptoms have not responded to other medications. […] As part of a comprehensive, personalized medical treatment plan, your gastroenterologist may prescribe or recommend medication that is not intended to address the cause of IBD. […] If a bacterial infection occurs as a complication of IBD, your doctor may prescribe antibiotics, which are taken by mouth or administered via IV infusion. […] For abdominal pain that does not respond to other IBD medications, gastroenterologists may recommend a prescription antispasmodic medication, which suppresses muscle spasms in the bowel, easing pain and discomfort. […] Gastroenterologists at NYU Langone understand that IBD symptoms can be painful. […] People with IBD often have vitamin or mineral deficiencies because digestive dysfunction prevents the body from absorbing important nutrients.

• #58 Medication for Inflammatory Bowel Disease | NYU Langone Health

  https://nyulangone.org/conditions/inflammatory-bowel-disease/treatments/medication-for-inflammatory-bowel-disease

  Anti-integrin therapy may be prescribed for people with severe IBD whose symptoms have not responded to other medications. […] As part of a comprehensive, personalized medical treatment plan, your gastroenterologist may prescribe or recommend medication that is not intended to address the cause of IBD. […] If a bacterial infection occurs as a complication of IBD, your doctor may prescribe antibiotics, which are taken by mouth or administered via IV infusion. […] For abdominal pain that does not respond to other IBD medications, gastroenterologists may recommend a prescription antispasmodic medication, which suppresses muscle spasms in the bowel, easing pain and discomfort. […] Gastroenterologists at NYU Langone understand that IBD symptoms can be painful. […] People with IBD often have vitamin or mineral deficiencies because digestive dysfunction prevents the body from absorbing important nutrients.

• #59 Inflammatory bowel disease

  https://womenshealth.gov/a-z-topics/inflammatory-bowel-disease

  Maybe. Almost 1 in 3 people with ulcerative colitis may need surgery to treat the ulcerative colitis at some point. […] The type of procedure your doctor does depends on your symptoms and how severe they are, your age, and how the procedure will affect your quality of life, such as the types of activities you do. […] Your doctor will talk to you about steps you can take at home to relieve your IBD symptoms. Some steps may include: Reducing stress. […] Changing your eating habits. Some women report that limiting or avoiding certain foods helps relieve symptoms. […] Taking vitamin supplements. Your doctor may suggest vitamin supplements if your body does not get all of the nutrients you need from food because of IBD. […] Taking probiotics. Some research suggests that probiotics, which are live bacteria similar to what is found naturally in the body, may help some people with IBD.

• #60 Does Mind-Body Therapy for Inflammatory Bowel Disease Help Patients? – Gastroenterology Advisor

  https://www.gastroenterologyadvisor.com/features/does-mind-body-therapy-for-inflammatory-bowel-disease-help-patients/

  Mind-body interventions have been shown to reduce depression and anxiety in patients with IBD, but the benefits may extend to improvements in IBD symptoms. […] Researchers have explored the effect of mind-body (or integrative) treatment strategies on psychological functioning, quality of life (QOL), and other outcomes in patients with IBD, a population with high rates of comorbid mental health disorders, such as depression and anxiety. […] In addition to high program adherence and low dropout rates, those in the treatment group showed significant improvements in perceived stress (22.4%), anxiety (23.7%), depression (29.5%), resilience (10.6%), and QOL (8.9%). […] Other findings have demonstrated a link between mind-body therapies and reductions in levels of inflammatory markers. […] The most effective mind-body approaches for IBD are CBT, especially for patients who have comorbid mood or anxiety, and mindfulness-based interventions.

• #61 Does Mind-Body Therapy for Inflammatory Bowel Disease Help Patients? – Gastroenterology Advisor

  https://www.gastroenterologyadvisor.com/features/does-mind-body-therapy-for-inflammatory-bowel-disease-help-patients/

  Mind-body interventions have been shown to reduce depression and anxiety in patients with IBD, but the benefits may extend to improvements in IBD symptoms. […] Researchers have explored the effect of mind-body (or integrative) treatment strategies on psychological functioning, quality of life (QOL), and other outcomes in patients with IBD, a population with high rates of comorbid mental health disorders, such as depression and anxiety. […] In addition to high program adherence and low dropout rates, those in the treatment group showed significant improvements in perceived stress (22.4%), anxiety (23.7%), depression (29.5%), resilience (10.6%), and QOL (8.9%). […] Other findings have demonstrated a link between mind-body therapies and reductions in levels of inflammatory markers. […] The most effective mind-body approaches for IBD are CBT, especially for patients who have comorbid mood or anxiety, and mindfulness-based interventions.

• #62 Does Mind-Body Therapy for Inflammatory Bowel Disease Help Patients? – Gastroenterology Advisor

  https://www.gastroenterologyadvisor.com/features/does-mind-body-therapy-for-inflammatory-bowel-disease-help-patients/

  Mind-body interventions have been shown to reduce depression and anxiety in patients with IBD, but the benefits may extend to improvements in IBD symptoms. […] Researchers have explored the effect of mind-body (or integrative) treatment strategies on psychological functioning, quality of life (QOL), and other outcomes in patients with IBD, a population with high rates of comorbid mental health disorders, such as depression and anxiety. […] In addition to high program adherence and low dropout rates, those in the treatment group showed significant improvements in perceived stress (22.4%), anxiety (23.7%), depression (29.5%), resilience (10.6%), and QOL (8.9%). […] Other findings have demonstrated a link between mind-body therapies and reductions in levels of inflammatory markers. […] The most effective mind-body approaches for IBD are CBT, especially for patients who have comorbid mood or anxiety, and mindfulness-based interventions.

• #63 Does Mind-Body Therapy for Inflammatory Bowel Disease Help Patients? – Gastroenterology Advisor

  https://www.gastroenterologyadvisor.com/features/does-mind-body-therapy-for-inflammatory-bowel-disease-help-patients/

  Mind-body interventions have been shown to reduce depression and anxiety in patients with IBD, but the benefits may extend to improvements in IBD symptoms. […] Researchers have explored the effect of mind-body (or integrative) treatment strategies on psychological functioning, quality of life (QOL), and other outcomes in patients with IBD, a population with high rates of comorbid mental health disorders, such as depression and anxiety. […] In addition to high program adherence and low dropout rates, those in the treatment group showed significant improvements in perceived stress (22.4%), anxiety (23.7%), depression (29.5%), resilience (10.6%), and QOL (8.9%). […] Other findings have demonstrated a link between mind-body therapies and reductions in levels of inflammatory markers. […] The most effective mind-body approaches for IBD are CBT, especially for patients who have comorbid mood or anxiety, and mindfulness-based interventions.

• #64 Does Mind-Body Therapy for Inflammatory Bowel Disease Help Patients? – Gastroenterology Advisor

  https://www.gastroenterologyadvisor.com/features/does-mind-body-therapy-for-inflammatory-bowel-disease-help-patients/

  Mind-body interventions have been shown to reduce depression and anxiety in patients with IBD, but the benefits may extend to improvements in IBD symptoms. […] Researchers have explored the effect of mind-body (or integrative) treatment strategies on psychological functioning, quality of life (QOL), and other outcomes in patients with IBD, a population with high rates of comorbid mental health disorders, such as depression and anxiety. […] In addition to high program adherence and low dropout rates, those in the treatment group showed significant improvements in perceived stress (22.4%), anxiety (23.7%), depression (29.5%), resilience (10.6%), and QOL (8.9%). […] Other findings have demonstrated a link between mind-body therapies and reductions in levels of inflammatory markers. […] The most effective mind-body approaches for IBD are CBT, especially for patients who have comorbid mood or anxiety, and mindfulness-based interventions.

• #65 Does Mind-Body Therapy for Inflammatory Bowel Disease Help Patients? – Gastroenterology Advisor

  https://www.gastroenterologyadvisor.com/features/does-mind-body-therapy-for-inflammatory-bowel-disease-help-patients/

  Studies have also demonstrated favorable results with CBT-based approaches in patients with IBD, including a 2021 RCT reporting improvements in stress levels, QOL, and relapse rates after participation in group-based CBT. […] Mind and body approaches are gaining interest in the management of IBD given the known impact of emotional well-being on outcomes, and vice versa. […] Despite the lack of high-grade scientific evidence, recommending mind-body interventions for IBD is still widely encouraged. […] The available evidence suggests that mind-body approaches such as mindfulness-based stress reduction (MBSR), cognitive-behavioral therapy (CBT), and yoga may offer some benefits in the treatment of IBD. […] The proposed mechanisms involved in the beneficial effects of mind-body approaches in IBD are not fully understood but may involve changes in the brain-gut axis, the immune system, and the stress response.

• #66 Crohn’s disease and ulcerative colitis | Better Health Channel

  https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/crohns-disease-and-ulcerative-colitis

  Crohns disease and ulcerative colitis are known as inflammatory bowel diseases (IBD). […] There are many treatment options for people living with IBD including medication, dietary strategies, surgery, and complementary and alternative medicine. Speak to your GP, gastroenterologist or dietitian about treatment options. […] Crohns disease cannot currently be cured but for most people it can be well managed through medication, lifestyle choices and sometimes surgery. Treatments may also need to change over time if they become less effective. […] Medications for Crohns disease are mainly used to reduce inflammation. The main types include: aminosalicylates, corticosteroids, immunosuppressants, biologics, antibiotics. […] Diet has an important role to play in many aspects of Crohns disease, including treating active disease, managing symptoms, ensuring nutritional adequacy and complications of Crohns disease. Diet may also potentially support remission.

• #67 5 major advances in inflammatory bowel disease (IBD) treatment – American Gastroenterological AssociationAGA Logo_Horizontal

  https://gastro.org/press-releases/5-major-advances-in-inflammatory-bowel-disease-ibd-treatment/

  There is no cure for Crohn’s disease and currently available drugs do not work for all patients, so advances in treatments are closely watched by physicians and patients. […] An early Phase I study shows promise for AZD4205 for the treatment of Crohn’s disease. […] IBD patients have an imbalance of gut bacteria, which contributes to inflammation. […] Researchers at UMASS Medical School developed the IBD-Anti-Inflammatory Diet (IBD-AID™) to restore the balance between helpful and harmful bacteria while promoting good nutrition. […] The rate of colectomy (surgical removal of a patient’s colon) within the first year after hospital admission for ulcerative colitis has declined in the modern era of biologics. […] Fecal microbiota transplantation (FMT) is still an emerging treatment for ulcerative colitis. […] This study is the first to reveal importance of FMT donor selection for long-term maintenance for ulcerative colitis.

• #68 5 major advances in inflammatory bowel disease (IBD) treatment – American Gastroenterological AssociationAGA Logo_Horizontal

  https://gastro.org/press-releases/5-major-advances-in-inflammatory-bowel-disease-ibd-treatment/

  There is no cure for Crohn’s disease and currently available drugs do not work for all patients, so advances in treatments are closely watched by physicians and patients. […] An early Phase I study shows promise for AZD4205 for the treatment of Crohn’s disease. […] IBD patients have an imbalance of gut bacteria, which contributes to inflammation. […] Researchers at UMASS Medical School developed the IBD-Anti-Inflammatory Diet (IBD-AID™) to restore the balance between helpful and harmful bacteria while promoting good nutrition. […] The rate of colectomy (surgical removal of a patient’s colon) within the first year after hospital admission for ulcerative colitis has declined in the modern era of biologics. […] Fecal microbiota transplantation (FMT) is still an emerging treatment for ulcerative colitis. […] This study is the first to reveal importance of FMT donor selection for long-term maintenance for ulcerative colitis.

• #69 Does Mind-Body Therapy for Inflammatory Bowel Disease Help Patients? – Gastroenterology Advisor

  https://www.gastroenterologyadvisor.com/features/does-mind-body-therapy-for-inflammatory-bowel-disease-help-patients/

  The psychological therapies address the thoughts and anxieties surrounding living with IBD and seek to re-engage the person with what is important in life. […] The relationship between the brain and the gut is complicated. […] Several studies have shown that psychological approaches to treating these aspects of living with IBD are helpful. […] Multidisciplinary treatment involving psychologists, dieticians, physical therapists, and others is the future of care and the best way to reduce complications and improve quality of life for the people we serve.

• #70 Inflammatory Bowel Disease (IBD): Symptoms, Diagnosis and Treatment | Nationwide Children’s Hospital

  https://www.nationwidechildrens.org/conditions/inflammatory-bowel-disease

  Nationwide Children’s Hospital offers a team of experts focused on the treatment of children and teens with inflammatory bowel disease. […] The aim of treatment is to heal the intestines and confirm this on repeat endoscopy. Even though a medical cure is not yet possible, control of symptoms and disease can be very effective in majority of patients. The number of medications available continues to increase and new treatments can be expected in the future. The most common medications used to treat IBD are: […] Nutritional therapy can be used to induce and maintain remission in Crohns disease. […] Because there is a high risk of recurrence after surgery, this option is reserved for complications such as an obstruction from a narrowed area of the intestine, fistulizing disease, abscesses, chronic pain, bleeding, or when using all other medicine does not work.

• #71 Inflammatory Bowel Disease (IBD) | Loma Linda University Health

  https://lluh.org/conditions/inflammatory-bowel-disease-ibd

  Diet and complementary and alternative therapies can be used as an addition to medical therapies. Your doctor may recommend a special diet given via a feeding tube, or nutrients injected into a vein to treat your IBD. If you have a stenosis or stricture in the bowel, your doctor may recommend a low fiber diet. […] Surgery can also be part of the treatment in cases of disease that does not respond to medications. It may also be needed if complications such as obstructions, fistulas or abscesses occur. The type of surgery needed depends on the involvement of the disease. […] For those with Crohn’s disease: About 50% of people with Crohn’s disease will require at least one surgery in their lifetime. Although surgery does not cure Crohn’s disease, it can help address the symptoms of CD. Surgery may be needed when there is an obstruction (or blockage), perforation (abnormal opening in the GI tract), infection that cannot be treated with antibiotics alone, and persistent disease that does not respond to medical therapy. During surgery, your surgeon may remove a damaged portion of your intestine. If possible, a reconnection of the bowel is performed. Without medical therapy, the disease often recurs; frequently, this happens near the reconnected tissue. The best approach is to follow surgery with medication to minimize the risk of recurrence.

• #72 Horizon scanning: new and future therapies in the management of inflammatory bowel disease | eGastroenterology

  https://egastroenterology.bmj.com/content/1/2/e100012

  The therapeutic arsenal for the management of IBD is being developed and repurposed at an accelerated rate. […] Small molecules have the added advantage of not carrying the risk of immunogenicity that occurs with biological drugs. […] Therefore, there is potential to use these medications on demand such as during disease flares, to avoid corticosteroid use, or in combination with a biologic to improve clinical remission by targeting multiple immune pathways.

• #73 Current Therapy in Inflammatory Bowel Disease: Why and How We Need to Change? – European Medical Journal

  https://www.emjreviews.com/innovations/article/current-therapy-in-inflammatory-bowel-disease-why-and-how-we-need-to-change-j080121/

  During the last few decades, major progress has been made in the treatment of the two major forms of inflammatory bowel disease (IBD): Crohns disease and ulcerative colitis. However, the success of the most advanced forms of therapy is at best 50%, and most patients lose responsiveness with time and need to switch to alternative medications. […] This denotes that a therapeutic ceiling has been reached and brand new approaches are badly needed. […] The current mainstay of IBD therapy is biological therapy, which is primarily based on monoclonal antibodies directed against specific molecules with immunomodulatory or inflammatory activity. […] Taken all together, response rates to biologics range anywhere from 20-50%. […] This unsatisfactory condition results directly from the single target-single medicine approach, and has remained unchanged for decades, indicating that a therapeutic ceiling has been reached, no matter what medication is prescribed.

• #74 Inflammatory Bowel Disease | Diagnosis & Treatment | IU Health

  https://iuhealth.org/find-medical-services/inflammatory-bowel-disease

  Many different types of medicines treat the symptoms of IBD such as nausea and diarrhea, as well as suppress to your immune system to reduce attacks on healthy intestinal cells. A combination of medicines put you into remission and keep you there. These types of therapies include anti-inflammatories, corticosteroids, antibiotics, immunomodulators and biologics. […] When complications of IBD cannot be handled medically, surgery can bring relief, but not a cure. GI surgeons will help you decide the best surgery for your specific symptoms. For Crohn’s disease, surgeries may include abscess drainage, opening of strictures, bowel resections or creation of an ostomy. […] IU Health researchers test new medicines, endoscopic procedures and other therapies, such as fecal transplants to treat inflammatory bowel disease or complications such as C difficile infection. Clinical trials at IU Health tested any of the new biologic medicines now available.

• #75 Inflammatory Bowel Disease (IBD) Program | Stanford Health Care | Stanford Health Care

  https://stanfordhealthcare.org/medical-clinics/inflammatory-bowel-disease-ibd-program.html

  With our ongoing research, you may have the opportunity to participate in clinical trials, advancing our knowledge of IBD and piloting new therapies. […] We are looking closely into the gut microbiome and researching how to reduce inflammation through nutritional therapy. […] Our gastroenterologists and other digestive health specialists meet weekly to review the most complicated cases. […] From advanced IBD drug therapies to minimally invasive colorectal surgery, our experts work together to select and plan the most effective treatment for you, to control your symptoms, give relief, and improve your quality of life. […] The right combination of therapies can lower your risk of complications and your need for future surgery. […] If you have Crohn’s disease or ulcerative colitis, your gastroenterologist will likely prescribe medication to help heal your digestive tract.

• #76 Pharmacological Therapy in Inflammatory Bowel Diseases: A Narrative Review of the Past 90 Years

  https://www.mdpi.com/1424-8247/16/9/1272

  The first immunomodulatory drugs with the possibility of long-term use, in order to maintain the remission of patients’ refractory to 5-ASA or corticosteroid-dependent or corticosteroid-refractory, were azathioprine, 6-mercaptopurine, and methotrexate, classically named immunomodulators. […] In the 1990s, the advent of immunobiological therapies reached the IBD therapeutic panel. Infliximab ushered in the era of biologics, medications that achieve higher rates of disease remission when compared to conventional therapies and that have reduced the rate of hospitalizations and resections over the past two decades. […] The JAK family is composed of JAK 1, JAK 2, JAK 3, and tyrosine kinase 2 (TKY2). An extracellular signal (cytokine) can bind to these receptors and induce their activation and, consequently, auto-phosphorylation, and/or transphosphorylation with subsequent interaction of the family composed of seven STATs (STAT 1, 2, 3, 4, 5A, and 5B) with subsequent translocation of information to the cell nucleus. […] The development of new molecules is a reality both for previously approved classes and for new therapeutic classes with different targets.

• #77 Current Treatments, Emerging Therapeutics, and Natural Remedies for Inflammatory Bowel Disease

  https://www.mdpi.com/1420-3049/29/16/3954

  The treatment option for IBD has further widened with the approvals of anti-integrins (vedolizumab and natalizumab), Janus kinase (JAK) inhibitors (tofacitinib, filgotinib, and upadacitinib), and anti-p19 antibodies (ustekinumab and risankizumab). […] Could combining multiple biologics be an alternative therapy to maximise efficacy with fewer side effects? Several studies have tried combination therapies (CoT) of biologics or biologics with SMD (e.g., anti-TNF + anti-integrins) against IBD. […] The advent of new biological and small-molecule therapies has made significant progress in the treatment landscape of IBD, and many more are in the pipeline. Janus kinase (JAK) inhibitors, immunosuppressants, and anti-trafficking molecules are a few examples. […] More IL-12/IL-23 inhibitors and anti-integrin/anti-adhesion agents are undergoing clinical assessment for their efficacy and safety in treating IBD.

• #78 Inflammatory Bowel Disease | Symptoms and Treatment

  https://patient.info/digestive-health/inflammatory-bowel-disease

  Inflammatory bowel disease treatment […] The treatment for inflammatory bowel disease will depend on the nature and severity of symptoms. Investigations, diagnosis and treatment are generally started in hospital. Urgent hospital admission may be needed if symptoms are very severe. […] Treatments may include dietary advice and medicines to help ease IBD symptoms (eg, steroids, and other medicines that can help keep symptoms under control). People with severe symptoms may require surgery to remove part of the bowel. […] Changes to diet may help to reduce symptoms. The dietary advice will depend on the symptoms and it’s essential to make sure you get enough energy and nutrients from your diet. […] A low-residue diet may also be used for IBD. This is a very restricted diet with less fibre. This diet can help to reduce symptoms such as diarrhoea and pain but needs supervision by a dietician.

• #79 Medication for Inflammatory Bowel Disease | NYU Langone Health

  https://nyulangone.org/conditions/inflammatory-bowel-disease/treatments/medication-for-inflammatory-bowel-disease

  Gastroenterologists at NYU Langone’s Inflammatory Bowel Disease Center and Inflammatory Bowel Disease CenterLong Island may prescribe one or more medications to reduce inflammation in the digestive tract caused by inflammatory bowel disease, or IBD. The goals of treatment are to improve symptoms and heal any damage to the intestines. […] Our gastroenterologists develop a personalized treatment plan for you based on the type of IBD, the severity of the condition, and the results of diagnostic tests. […] Medications for IBD can often reduce inflammation and promote healing in the intestines, resulting in remissionmeaning long-term symptom relief. However, for many people with IBD, the condition is chronic and treatment is lifelong. It is very important to follow up regularly with your gastroenterologist.

• #80 Finding the Right IBD Therapy for Patients: A Q&A with Jill Gaidos, MD < Yale School of Medicine

  https://medicine.yale.edu/news-article/finding-the-right-ibd-therapy/

  The great news is that even though many of these therapies are newer to the market, their safety profiles are very, very good. The risk of infection is low, and we havent seen any increased risk of cancers. The biggest worry with the use of upadacitinib is shingles, so we encourage all of our patients to get the shingles vaccine. […] For newly diagnosed patients, we focus on what medication fits best in their lifestyle. Are they comfortable injecting themselves? Will they remember to take a pill every day, or would they prefer to come in every two months for an infusion and then be done with it? […] The reality is that we also need to understand what their insurance will pay for. All these medications are very expensive, so without adequate insurance coverage, it wont be feasible for most patients. We work closely with our clinical pharmacy team to help get insurance approval or find a patient assistance program to help every patient get access to treatment.

• #81 Finding the Right IBD Therapy for Patients: A Q&A with Jill Gaidos, MD < Yale School of Medicine

  https://medicine.yale.edu/news-article/finding-the-right-ibd-therapy/

  The great news is that even though many of these therapies are newer to the market, their safety profiles are very, very good. The risk of infection is low, and we havent seen any increased risk of cancers. The biggest worry with the use of upadacitinib is shingles, so we encourage all of our patients to get the shingles vaccine. […] For newly diagnosed patients, we focus on what medication fits best in their lifestyle. Are they comfortable injecting themselves? Will they remember to take a pill every day, or would they prefer to come in every two months for an infusion and then be done with it? […] The reality is that we also need to understand what their insurance will pay for. All these medications are very expensive, so without adequate insurance coverage, it wont be feasible for most patients. We work closely with our clinical pharmacy team to help get insurance approval or find a patient assistance program to help every patient get access to treatment.

• #82 Finding the Right IBD Therapy for Patients: A Q&A with Jill Gaidos, MD < Yale School of Medicine

  https://medicine.yale.edu/news-article/finding-the-right-ibd-therapy/

  With IBD, there are multiple pathways that can cause inflammation. For that reason, patients often need to try multiple medications to find one that works. […] I try to set expectations beforehand so patients know how fast a medicine should work. If theyre not feeling better by that time point, we can switch their medication or increase their dosage. […] However, while the research is encouraging, theres still much more to learn. […] Most patients with IBD can successfully manage their disorder with a community doctor. […] With so many treatments available, it can be difficult for doctors, especially those who dont specialize in IBD, to stay up to date on all the options. […] Ultimately, patients need to trust their doctors. We talk about very intimate things, and our patients need to feel comfortable sharing details with us so that we can treat them appropriately. Open communication is critical.

• #83 Finding the Right IBD Therapy for Patients: A Q&A with Jill Gaidos, MD < Yale School of Medicine

  https://medicine.yale.edu/news-article/finding-the-right-ibd-therapy/

  With IBD, there are multiple pathways that can cause inflammation. For that reason, patients often need to try multiple medications to find one that works. […] I try to set expectations beforehand so patients know how fast a medicine should work. If theyre not feeling better by that time point, we can switch their medication or increase their dosage. […] However, while the research is encouraging, theres still much more to learn. […] Most patients with IBD can successfully manage their disorder with a community doctor. […] With so many treatments available, it can be difficult for doctors, especially those who dont specialize in IBD, to stay up to date on all the options. […] Ultimately, patients need to trust their doctors. We talk about very intimate things, and our patients need to feel comfortable sharing details with us so that we can treat them appropriately. Open communication is critical.

• #84 Approach to Treatment Failure in Inflammatory Bowel Disease – Gastroenterology & Hepatology

  https://www.gastroenterologyandhepatology.net/archives/june-2022/approach-to-treatment-failure-in-inflammatory-bowel-disease/

  Thankfully, over time, there has been a small incremental decline in the proportion of patients who need surgery, particularly in ulcerative colitis and less so in Crohn’s disease. […] There are 2 parts to monitoring. The first involves safety and monitoring for side effects. […] It is important to have good communication with patients to flag early whose therapy is failing and why, as well as to use objective measures to try to tease out patients who have complications in whom more drug may not be the best solution vs patients who have inadequate drug levels vs patients who just have a refractory inflammatory pathway. […] The most common one in recent years has been that every biologic failure is because of inadequate drug levels. It is now known that only 20% to 30% of patients who fail a biologic do so because of inadequate dosing or drug levels.

• #85 Approach to Treatment Failure in Inflammatory Bowel Disease – Gastroenterology & Hepatology

  https://www.gastroenterologyandhepatology.net/archives/june-2022/approach-to-treatment-failure-in-inflammatory-bowel-disease/

  Thankfully, over time, there has been a small incremental decline in the proportion of patients who need surgery, particularly in ulcerative colitis and less so in Crohn’s disease. […] There are 2 parts to monitoring. The first involves safety and monitoring for side effects. […] It is important to have good communication with patients to flag early whose therapy is failing and why, as well as to use objective measures to try to tease out patients who have complications in whom more drug may not be the best solution vs patients who have inadequate drug levels vs patients who just have a refractory inflammatory pathway. […] The most common one in recent years has been that every biologic failure is because of inadequate drug levels. It is now known that only 20% to 30% of patients who fail a biologic do so because of inadequate dosing or drug levels.

• #86 Inflammatory Bowel Disease (IBD)

  https://myhealth.alberta.ca/Health/aftercareinformation/pages/conditions.aspx?HwId=custom.ab_ibd_new_medicine_inst

  For biologics to work as well as possible, it is important to follow your healthcare providers instructions about when to take your medicine and how to monitor your treatment. […] Because many of the medicines used to treat IBD slow down your immune system, they can increase your risk of infections. […] To further help lower your risk of infection, you will be asked to do tests to make sure you do not have chronic infections such as hepatitis B or tuberculosis. […] During your treatment for IBD, you will be asked to do routine blood and stool tests to monitor how well the treatment is working and if you are having any side effects. […] Follow-up care is a key part of your treatment and safety. Be sure to make and go to all appointments and have your routine monitoring tests done.

• #87 Inflammatory Bowel Disease (IBD)

  https://myhealth.alberta.ca/Health/aftercareinformation/pages/conditions.aspx?HwId=custom.ab_ibd_new_medicine_inst

  For biologics to work as well as possible, it is important to follow your healthcare providers instructions about when to take your medicine and how to monitor your treatment. […] Because many of the medicines used to treat IBD slow down your immune system, they can increase your risk of infections. […] To further help lower your risk of infection, you will be asked to do tests to make sure you do not have chronic infections such as hepatitis B or tuberculosis. […] During your treatment for IBD, you will be asked to do routine blood and stool tests to monitor how well the treatment is working and if you are having any side effects. […] Follow-up care is a key part of your treatment and safety. Be sure to make and go to all appointments and have your routine monitoring tests done.

• #88 Inflammatory Bowel Disease (IBD) Basics | IBD | CDC

  https://www.cdc.gov/inflammatory-bowel-disease/about/index.html

  IBD can lead to health complications both inside the gastrointestinal (GI) tract and outside the GI tract (called „extraintestinal manifestations”). […] Keeping up with medication is the best way to control IBD symptoms and flare-ups. […] Common medications include: […] Surgery: This may be done to remove or widen the areas of the intestines that have been severely affected. It is typically considered after other treatments have failed. […] The effects of IBD may seem intimidating, but the right treatment can control symptoms and allow people to get back to doing the things they love.

• #89 Inflammatory Bowel Disease: Not Curable, But Treatable | BIDMC of Boston

  https://www.bidmc.org/about-bidmc/wellness-insights/gastrointestinal-gi-health/2016/04/inflammatory-bowel-disease-not-curable-but-treatable

  Although IBD is a chronic disease, it is treatable. […] Physicians and patients should work together to develop a treatment plan, with goals of controlling the symptoms and the inflammation, getting the patient feeling back to normal, keeping them feeling normal, and minimizing medication side effects, Cheifetz says. […] Since 1997, when Cheifetz was first diagnosed, powerful new medications called biologics have been developed to treat IBD. […] There are currently six biologic therapies approved for the treatment of IBD. […] The key to success with all medications is taking them as prescribed. Not taking medications as prescribed can lead to flares of the disease. […] He is deeply committed to research aimed at improving treatment options, and is currently focusing on the use of therapeutic drug monitoring to optimize anti-inflammatory therapies to treat patients diagnosed with IBD.

• #90 Inflammatory Bowel Disease: Not Curable, But Treatable | BIDMC of Boston

  https://www.bidmc.org/about-bidmc/wellness-insights/gastrointestinal-gi-health/2016/04/inflammatory-bowel-disease-not-curable-but-treatable

  Although IBD is a chronic disease, it is treatable. […] Physicians and patients should work together to develop a treatment plan, with goals of controlling the symptoms and the inflammation, getting the patient feeling back to normal, keeping them feeling normal, and minimizing medication side effects, Cheifetz says. […] Since 1997, when Cheifetz was first diagnosed, powerful new medications called biologics have been developed to treat IBD. […] There are currently six biologic therapies approved for the treatment of IBD. […] The key to success with all medications is taking them as prescribed. Not taking medications as prescribed can lead to flares of the disease. […] He is deeply committed to research aimed at improving treatment options, and is currently focusing on the use of therapeutic drug monitoring to optimize anti-inflammatory therapies to treat patients diagnosed with IBD.

• #91 Inflammatory Bowel Disease: Not Curable, But Treatable | BIDMC of Boston

  https://www.bidmc.org/about-bidmc/wellness-insights/gastrointestinal-gi-health/2016/04/inflammatory-bowel-disease-not-curable-but-treatable

  Although IBD is a chronic disease, it is treatable. […] Physicians and patients should work together to develop a treatment plan, with goals of controlling the symptoms and the inflammation, getting the patient feeling back to normal, keeping them feeling normal, and minimizing medication side effects, Cheifetz says. […] Since 1997, when Cheifetz was first diagnosed, powerful new medications called biologics have been developed to treat IBD. […] There are currently six biologic therapies approved for the treatment of IBD. […] The key to success with all medications is taking them as prescribed. Not taking medications as prescribed can lead to flares of the disease. […] He is deeply committed to research aimed at improving treatment options, and is currently focusing on the use of therapeutic drug monitoring to optimize anti-inflammatory therapies to treat patients diagnosed with IBD.

• #92 Inflammatory Bowel Disease (IBD) | ACG

  https://gi.org/topics/inflammatory-bowel-disease/

  With early and proper treatment, most patients with IBD lead healthy and productive lives. Studies have shown reduction in need for hospitalization and surgery in significant number of patients with medical therapy. […] Currently, there is no cure for Crohn’s disease. But treatments work differently in different people. There are many goals of treatment. They are to relieve symptoms and improve your quality of life. Also to heal the inflammation and prevent damage. […] If other treatments do not work or if a complication happens, then surgery can be done. This is just a short-term fix though. Surgery will not cure the Crohn’s disease. The surgeon just removes the damaged or abnormal part of the digestive tract and reconnects the healthy areas. About half of the people with Crohn’s disease need surgery over the course of their lifetime.

Zobacz więcej